Screener
Biote Corp. BTMD Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$7.43M-289% | $2.68M-83.1% | $2.62M-24.9% | $9.22M-27.2% | $3.93M+138% | ||
| $963K+5.8% | $980K+14.4% | $951K-16.4% | $952K+17.5% | $910K+3.9% | ||
| $1.97M-9.9% | $1.76M-17.3% | $2.2M+16.5% | $2.41M+7.3% | $2.19M-23.1% | ||
| —— | $3.9M-39.7% | $7.57M-38.8% | $14.07M-9.5% | $7.09M-28.8% | ||
| $2.56M+41.3% | $362K-77.8% | $1.08M-35.5% | $499K-67.8% | $1.81M-27.8% | ||
| -$2.62M-33.7% | -$1.17M+36.8% | -$2.36M-80.3% | -$690K+65.0% | -$1.96M+41.2% | ||
| $616K-30.6% | $405K-41.6% | $138K+56.8% | $8K-98.2% | $887K-78.5% | ||
| $4.79M+470% | $1.07M+27.3% | $841.25K— | $841.25K— | $841.25K-44.3% | ||
| $5M+300% | $7.5M+500% | $1.25M— | $1.25M— | $1.25M— | ||
| $10M— | $7.5M— | —— | —— | —— | ||
| —— | -$21.54M-854% | -$9.13M+8.1% | -$4.94M-179% | -$27.23M+53.8% | ||
| —— | -$18.8M-897% | -$3.93M— | —— | -$22.1M+57.8% | ||
| -$3.73M-171% | $3.54M-26.8% | $6.49M-39.3% | $13.57M-3.1% | $5.28M-29.1% |
FAQ
- What is Biote Corp.'s free cash flow?
- After $4.5M of capital expenditures, Biote Corp.'s free cash flow was $19.9M over the trailing twelve months, down 42.9% year over year.
- Where does Biote Corp.'s cash flow data come from?
- Every line is extracted from Biote Corp.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
